Skip to main content

GeneDx Holdings Corp. (WGS)

Sector
Health Care
Last price
$64.96
As of

Kresmion compiles this page from WGS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

GeneDx Holdings Corp. (WGS): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-03.

As of . Source: SEC EDGAR filings for WGS. Method and limitations.

COMPANY DOSSIER

See the full WGS dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for WGS on one page. Preview it with sample data, then open it live with a free account.

Preview the WGS dossier

Active signals for WGS

FREE, NO ACCOUNT

Every signal on WGS, as it fires

You are seeing 5 of 22 signals recorded on WGS since 2026-06-01.

The five above landed across 2 days. The other 17 were recorded on 4 other days. 14 of the 22 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in WGS (2026Q2)

Manager / securityMarket value% portfolioQoQ
CITADEL ADVISORS LLCCUSIP 81663L200 · 2026Q2$59.4M0.01%,
MILLENNIUM MANAGEMENT LLCCUSIP 81663L200 · 2026Q2$10.7M0.00%,
Point72 Asset Management, L.P.CUSIP 81663L200 · 2026Q2$6.7M0.01%,
D. E. Shaw & Co., Inc.CUSIP 81663L200 · 2026Q2$2.7M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 81663L200 · 2026Q2$733K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, WGS

WGS against its peers

WGS's operating margin of -3.1% ranks in the 26th percentile of 24 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-03.

MetricWGSPeer medianPercentilen
Revenue FY428M USD1.0B USD1725
Gross margin69.7%54.6%7517
Operating margin-3.1%3.3%2624
Net margin-4.9%0.2%2925
Return on equity-6.8%1.6%3024
P / En/a35.6xn/a12
1 year-46.3%0.9%623

Peers (25): LMAT, INSP, SEM, XRAY, ATEC, PGNY, NVCR, MD, OMCL, ALHC, BKD, AMN, PNTG, CERT, AVAH, PRVA, TMDX, CNMD, ACHC, OMDA, USPH, ATRC, TNDM, GDRX, PRCT. Fiscal periods ending between 2025-12-31 and 2026-01-03. Every figure is one full fiscal year read from one annual filing (WGS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Follow WGS on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to WGS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the WGS dossier
Share

The WGS intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.